Alergia y Covid-19

Atopic diseases, especially asthma may confer increased susceptibility to viral infections, however, such patients have been largely unaffected in the current Covid-19 pandemic. This favorable course could be explained by a protective role of cytokines and cells involved in an immune response with a T2 profile. In spite of the favorable course observed, it is a priority to maintain with its basic treatments to ensure a good control of the pathology. With respect the immunization process being carried out in patients with a history of allergic reactions in different degrees, the recommendation of the type of vaccine and the protocol for its administration should be individualized according to a risk stratification prior to its administration.